We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Viiv HIV Treatment Approved by European Commission
Viiv HIV Treatment Approved by European Commission
The European Commission has approved ViiV Healthcare’s long-acting HIV treatment Vocabria (cabotegravir) for use in combination with Janssen’s Rekambys (rilpivirine) and Edurant (rilpivirine).